Capricor Inc.
Quick facts
Phase 3 pipeline
- Deramiocel (CAP-1002) · Cardiovascular
Deramiocel is an allogeneic cardiosphere-derived cell therapy that promotes cardiac repair and reduces inflammation following myocardial injury.
Phase 2 pipeline
- CAP-1002 · Cardiovascular
CAP-1002 is an allogeneic cardiosphere-derived cell therapy that promotes cardiac repair and regeneration through paracrine signaling and immunomodulation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: